JP2009540852A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009540852A5 JP2009540852A5 JP2009517228A JP2009517228A JP2009540852A5 JP 2009540852 A5 JP2009540852 A5 JP 2009540852A5 JP 2009517228 A JP2009517228 A JP 2009517228A JP 2009517228 A JP2009517228 A JP 2009517228A JP 2009540852 A5 JP2009540852 A5 JP 2009540852A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- seq
- antigen
- nos
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 29
- 150000007523 nucleic acids Chemical class 0.000 claims 24
- 108090000765 processed proteins & peptides Proteins 0.000 claims 21
- 108020004707 nucleic acids Proteins 0.000 claims 17
- 102000039446 nucleic acids Human genes 0.000 claims 17
- 108090000623 proteins and genes Proteins 0.000 claims 17
- 239000000427 antigen Substances 0.000 claims 16
- 239000012634 fragment Substances 0.000 claims 16
- 102000036639 antigens Human genes 0.000 claims 15
- 108091007433 antigens Proteins 0.000 claims 15
- 229920001184 polypeptide Polymers 0.000 claims 14
- 102000004196 processed proteins & peptides Human genes 0.000 claims 14
- 206010060862 Prostate cancer Diseases 0.000 claims 10
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 10
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 9
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 9
- 239000003446 ligand Substances 0.000 claims 9
- 239000002773 nucleotide Substances 0.000 claims 6
- 125000003729 nucleotide group Chemical group 0.000 claims 6
- 102000004169 proteins and genes Human genes 0.000 claims 5
- 239000012636 effector Substances 0.000 claims 4
- 238000009007 Diagnostic Kit Methods 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 238000001514 detection method Methods 0.000 claims 3
- 101710112752 Cytotoxin Proteins 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 claims 2
- 108090000790 Enzymes Proteins 0.000 claims 2
- 210000001744 T-lymphocyte Anatomy 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 230000003321 amplification Effects 0.000 claims 2
- 210000000612 antigen-presenting cell Anatomy 0.000 claims 2
- 238000003556 assay Methods 0.000 claims 2
- 210000004027 cell Anatomy 0.000 claims 2
- 229940030156 cell vaccine Drugs 0.000 claims 2
- 230000007969 cellular immunity Effects 0.000 claims 2
- 231100000599 cytotoxic agent Toxicity 0.000 claims 2
- 239000002619 cytotoxin Substances 0.000 claims 2
- 210000004443 dendritic cell Anatomy 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 239000003102 growth factor Substances 0.000 claims 2
- 238000003199 nucleic acid amplification method Methods 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 102000053642 Catalytic RNA Human genes 0.000 claims 1
- 108090000994 Catalytic RNA Proteins 0.000 claims 1
- 108020004414 DNA Proteins 0.000 claims 1
- 238000012286 ELISA Assay Methods 0.000 claims 1
- 108091034117 Oligonucleotide Proteins 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 230000000890 antigenic effect Effects 0.000 claims 1
- 230000027455 binding Effects 0.000 claims 1
- 238000012875 competitive assay Methods 0.000 claims 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims 1
- 229910052738 indium Inorganic materials 0.000 claims 1
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 210000002307 prostate Anatomy 0.000 claims 1
- 210000005267 prostate cell Anatomy 0.000 claims 1
- 108091092562 ribozyme Proteins 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 150000003384 small molecules Chemical class 0.000 claims 1
- 230000009870 specific binding Effects 0.000 claims 1
- 229910052727 yttrium Inorganic materials 0.000 claims 1
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81768606P | 2006-07-03 | 2006-07-03 | |
| PCT/EP2007/056584 WO2008003656A2 (en) | 2006-07-03 | 2007-06-29 | Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009540852A JP2009540852A (ja) | 2009-11-26 |
| JP2009540852A5 true JP2009540852A5 (https=) | 2010-08-05 |
Family
ID=38537749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009517228A Pending JP2009540852A (ja) | 2006-07-03 | 2007-06-29 | 前立腺特異的な転写物ならびに前立腺癌の治療および診断におけるその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20120141376A1 (https=) |
| EP (1) | EP2044216A2 (https=) |
| JP (1) | JP2009540852A (https=) |
| KR (1) | KR20090111307A (https=) |
| CN (1) | CN101506376A (https=) |
| AU (1) | AU2007271232A1 (https=) |
| CA (1) | CA2656140A1 (https=) |
| IL (1) | IL196184A0 (https=) |
| WO (1) | WO2008003656A2 (https=) |
| ZA (1) | ZA200900794B (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102110469B1 (ko) * | 2009-05-12 | 2020-05-14 | 코닌클리케 필립스 엔.브이. | 악성의 호르몬 민감성 전립선 암에 대한 마커로서의 포스포디에스테라제 4ｄ7 |
| DE102012203547A1 (de) * | 2012-03-07 | 2013-09-12 | Robert Bosch Gesellschaft Für Medizinische Forschung Mbh | Antimikrobielle Peptide |
| MY193914A (en) * | 2012-03-05 | 2022-11-01 | Oy Arctic Partners Ab | Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume |
| US12326453B2 (en) | 2014-03-28 | 2025-06-10 | Opko Diagnostics, Llc | Compositions and methods for active surveillance of prostate cancer |
| DK3123381T3 (da) | 2014-03-28 | 2023-11-27 | Opko Diagnostics Llc | Sammensætninger og fremgangsmåder relateret til diagnose af prostatacancer |
| KR101698654B1 (ko) * | 2014-12-24 | 2017-01-20 | 포항공과대학교 산학협력단 | En2에 특이적으로 결합하는 dna 압타머 및 이의 용도 |
| WO2016160545A1 (en) | 2015-03-27 | 2016-10-06 | Opko Diagnostics, Llc | Prostate antigen standards and uses thereof |
| ES3007999T3 (en) * | 2015-04-21 | 2025-03-21 | Genentech Inc | Compositions and methods for prostate cancer analysis |
| CA2995248A1 (en) * | 2015-09-02 | 2017-03-09 | Regeneron Pharmaceuticals, Inc. | Rodent model of prostate cancer |
| KR101777085B1 (ko) | 2017-02-23 | 2017-09-11 | 주식회사 성균바이오텍 | En2 단백질의 면역원성 단편 펩타이드 또는 이를 특이적으로 인식하는 항체 조성물 |
| CN119932188A (zh) * | 2018-02-22 | 2025-05-06 | 液体活检研究有限责任公司 | 用于前列腺癌检测和治疗的方法 |
| CA3137568A1 (en) * | 2019-04-25 | 2020-10-29 | Actinium Pharmaceuticals, Inc. | Compositions and methods of immunodepletion for the treatment of malignant and non-malignant hematological diseases |
| CN111383757B (zh) * | 2020-03-04 | 2023-08-25 | 南京亿科人群健康研究院有限公司 | 一种计算机辅助开发包虫病诊断试剂盒的方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2775984B1 (fr) * | 1998-03-11 | 2006-09-15 | Bioscreen Therapeutics Sa | Criblage differentiel qualitatif |
| AU3305699A (en) * | 1998-02-26 | 1999-09-15 | Beckman Coulter, Inc. | Prostate-specific membrane antigens and methods of making and using |
| WO2001055301A2 (en) * | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
| US20030099974A1 (en) * | 2001-07-18 | 2003-05-29 | Millennium Pharmaceuticals, Inc. | Novel genes, compositions, kits and methods for identification, assessment, prevention, and therapy of breast cancer |
| US20040126762A1 (en) * | 2002-12-17 | 2004-07-01 | Morris David W. | Novel compositions and methods in cancer |
| JP2005519606A (ja) * | 2002-03-14 | 2005-07-07 | エグゾニ・テラピューティック・ソシエテ・アノニム | ヒトカリクレイン−２及びカリクレイン−３のバリアント並びにそれらの使用 |
| WO2004113571A2 (en) * | 2003-06-26 | 2004-12-29 | Exonhit Therapeutics Sa | Prostate specific genes and the use thereof as targets for prostate cancer therapy and diagnosis |
-
2007
- 2007-06-29 AU AU2007271232A patent/AU2007271232A1/en not_active Abandoned
- 2007-06-29 KR KR1020097002135A patent/KR20090111307A/ko not_active Withdrawn
- 2007-06-29 JP JP2009517228A patent/JP2009540852A/ja active Pending
- 2007-06-29 US US12/309,478 patent/US20120141376A1/en not_active Abandoned
- 2007-06-29 CN CNA2007800252509A patent/CN101506376A/zh active Pending
- 2007-06-29 CA CA002656140A patent/CA2656140A1/en not_active Abandoned
- 2007-06-29 WO PCT/EP2007/056584 patent/WO2008003656A2/en not_active Ceased
- 2007-06-29 EP EP07786944A patent/EP2044216A2/en not_active Withdrawn
-
2008
- 2008-12-25 IL IL196184A patent/IL196184A0/en unknown
-
2009
- 2009-02-02 ZA ZA200900794A patent/ZA200900794B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009540852A5 (https=) | ||
| JP2005504513A5 (https=) | ||
| Gallotta et al. | Inhaled TLR9 agonist renders lung tumors permissive to PD-1 blockade by promoting optimal CD4+ and CD8+ T-cell interplay | |
| JP2007537197A5 (https=) | ||
| AU2019334261B2 (en) | Process for preparing vaccine compositions | |
| US20190345228A1 (en) | Targeted therapeutic agents comprising multivalent protein-biopolymer fusions | |
| JP2006515749A5 (https=) | ||
| JP2021514178A5 (https=) | ||
| DK1759013T3 (da) | Identificering af overflade-associerede antigener til tumordiagnose | |
| WO2014017491A1 (ja) | Ｃｅｐ５５遺伝子とｒｅｔ遺伝子との融合遺伝子 | |
| AU2015249374A1 (en) | Tumor suppressor and oncogene biomarkers predictive of anti-immune checkpoint inhibitor response | |
| JP2009039107A5 (https=) | ||
| WO2018148378A1 (en) | Modulating biomarkers to increase tumor immunity and improve the efficiacy of cancer immunotherapy | |
| JP2012520663A5 (https=) | ||
| JP7289029B2 (ja) | 分子誘導システムペプチド及びその使用 | |
| KR20210086612A (ko) | 펩타이드 백신 | |
| WO2009068621A1 (en) | Method for classifying cancer patients as responder or non-responder to immunotherapy | |
| RU2016138428A (ru) | Пептиды neil3 и включающие их вакцины | |
| KR20130055553A (ko) | 환자가 면역치료제에 대한 반응자일지의 여부를 확인하는 방법 | |
| KR20090016671A (ko) | 레플리킨 펩티드 및 이의 용도 | |
| CN107551264B (zh) | L3和/或l5源作为寄生虫病疫苗或诊断的用途 | |
| CN109468326A (zh) | 一种cd4+t核酸适配体及其应用 | |
| WO2004067564B1 (en) | Compositions against cancer antigen liv-1 and uses thereof | |
| CN102498219A (zh) | 在得自对象的生物学样品中评价癌症的方法 | |
| KR20170140328A (ko) | 암 치료용 면역요법제로서의 재조합 미코박테리움 |